A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17501
PubMed Identifier: 33961292
Publication URI: http://europepmc.org/abstract/MED/33961292
Type: Journal Article/Review
Volume: 194
Parent Publication: British journal of haematology
Issue: 2
ISSN: 0007-1048